Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Date:8/7/2014

for the second quarter of 2013.Cash, cash equivalents and marketable securities (Cash) were $63.6 million as of June 30, 2014.

Year to Date June 30, 2014 Key Financial Figures(1) (2) Six Months EndedJune 30,June 30,($ in thousands, except per share amounts)

20142013  Change ($)Change (%)Total revenues

$
20,005
$
,387
$
3,618
22%Research & development  expenses

10,77714,211(3,434)(24%)Selling, general & administrative expenses

56,0329,41346,619495%Non-cash stock-based compensation (3)

2,8362,43240417%Net loss

(48,108)(7,902)(40,206)(509%)Diluted net loss per share

$
(1.42)
$
(0.28)
$
(1.14)
(407%) 

Second Quarter 2014 Key Financial Figures(1) (2) Three Months EndedJune 30,March 31,($ in thousands, except per share amounts)

20142014  Change ($)Change (%)Total revenues

$
,862
$
9,143

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2013 Results
2. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
3. Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
4. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
5. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
6. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
7. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
8. Vanda Pharmaceuticals, Inc. Sued by Investor
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
11. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Tobramycin is a traditional antibiotic whose eye ... for the treatment of potential infection or inflammation caused ... China are able to produce tobramycin, ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Quetiapine Market, 2010-2019" ... by AstraZeneca plc, quetiapine (under the trade name ... treatment of schizophrenia. Approved by CFDA to treat ... Catalogue of Drugs for the Basic National Medical ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/sqh7xc/investigation ) ... on China,s Ranibizumab Market, 2012-2019" report to their ... by CFDA to treat wet age- related macular degeneration ... Novartis, is available in the Chinese market. However, in ... the treatment of wet AMD in China ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now available ... $49.00 was required to qualify for free standard shipping,” said Jennifer Ramirez, the public ... regardless of the item’s selling price.” , With competitive pricing in the e-commerce market ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops ... seconds of unique footage that users can shrink and stretch in the Final Cut ... Users can customize color, brightness, scale, speed, range, and flare attributes with intuitive controls ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain have ... soft tissue manipulation. Platelet rich plasma injections also have mixed results. Building ... treatment outcomes. This localized treatment seems to address the symptoms and does ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... freely market and sell Arterosil and Arterosil HP, and that all claims and ... sued Vascular Health Sciences, LLC (VHS) in the United States District Court for ...
(Date:8/28/2015)... Madre, CA (PRWEB) , ... August 28, 2015 ... ... solutions to wound center management, Decatur County Memorial Hospital recently transitioned management companies ... model of Wound Center Management for their outpatient wound center. , Transitioning ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... 21 (HealthDay News) -- Physically unfit men who do heavy ... a new study says. It also found that income ... socioeconomic levels are more likely to have lifestyle risk factors ... in lower and higher socioeconomic levels. Thirty percent of the ...
... Ill. -- Many premature infants suffer a life-threatening ... a Loyola University Medical Center study has identified a ... blood type who develop NEC are nearly three times ... other blood types., The finding suggests that a simple ...
... A team of University of Missouri researchers have found that ... the severity of the disease Spinal Muscular Atrophy (SMA) ... "When we introduced synthetic RNA into mice that carry ... lowered," said Chris Lorson, researcher at the Bond Life Sciences ...
... HealthDay Reporter , MONDAY, Nov. 21 (HealthDay News) -- ... Monday issued new recommendations on breast cancer screening, and ... a U.S. governmental panel. As the U.S. Preventive ... government-appointed Canadian panel of experts is also suggesting that ...
... (HealthDay News) -- ,Death rates for U.S. patients with throat and ... The finding comes from an analysis of National Center for ... 25 to 64, in 26 states. The researchers also ... throat (pharynx) cancers were among black patients with at least 12 ...
... , MONDAY, Nov. 21 (HealthDay News) -- Young ... death decades later, according to a new study. High ... disease and stroke but most of the evidence supporting this ... For this investigation of the long-term impact of elevated ...
Cached Medicine News:Health News:Life-threatening condition in preemies linked to blood type 2Health News:New Canadian Guidelines Also Support No Routine Mammograms Until 50 2Health News:New Canadian Guidelines Also Support No Routine Mammograms Until 50 3Health News:Fewer Dying in U.S. From Throat, Mouth Cancer, Study Finds 2Health News:Hypertension in Young Adulthood May Mean Trouble Later On 2
... Dissectron ultrasonic aspirator, ... ultrasonic surgical aspirator for ... of tissue available only ... Gathers in a very ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Medicine Products: